Cancer immunotherapy targeting neoantigens

Por Lu, Yong-Chen, Robbins, Paul F.
Publicado no Semin Immunol (2015)

Targeting neoantigens for cancer immunotherapy

Por Lu, Yong-Chen, Robbins, Paul F.
Publicado no Int Immunol (2016)

Selective Growth, In Vitro and In Vivo, of Individual T Cell Clones from Tumor-Infiltrating Lymphocytes Obtained from Patients with Melanoma

Por Zhou, Juhua, Dudley, Mark E., Rosenberg, Steven A., Robbins, Paul F.
Publicado em 2004

Persistence of Multiple Tumor-Specific T-Cell Clones Is Associated with Complete Tumor Regression in a Melanoma Patient Receiving Adoptive Cell Transfer Therapy

Por Zhou, Juhua, Dudley, Mark E., Rosenberg, Steven A., Robbins, Paul F.
Publicado em 2005

Induction of CD4(+) Th1 Lymphocytes That Recognize Known and Novel Class II MHC Restricted Epitopes from the Melanoma Antigen gp100 by Stimulation with Recombinant Protein

Por Parkhurst, Maria R., Riley, John P., Robbins, Paul F., Rosenberg, Steven A.
Publicado em 2004

Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

Por Powell, Daniel J., Dudley, Mark E., Robbins, Paul F., Rosenberg, Steven A.
Publicado em 2004

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production

Por Zeng, Gang, Wang, Xiang, Robbins, Paul F., Rosenberg, Steven A., Wang, Rong-Fu
Publicado em 2001

Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy

Por Zhou, Juhua, Shen, Xinglei, Hodes, Richard J., Rosenberg, Steven A., Robbins, Paul F.
Publicado em 2005

Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4(+) T Lymphocytes

Por Maccalli, Cristina, Li, Yong F., El-Gamil, Mona, Rosenberg, Steven A., Robbins, Paul F.
Publicado em 2003

Primary Human Lymphocytes Transduced with NY-ESO-1 Antigen-Specific TCR Genes Recognize and Kill Diverse Human Tumor Cell Lines

Por Zhao, Yangbing, Zheng, Zhili, Robbins, Paul F., Khong, Hung T., Rosenberg, Steven A., Morgan, Richard A.
Publicado em 2005

Mining the Melanosome for Tumor Vaccine Targets: P.polypeptide Is a Novel Tumor-associated Antigen

Por Touloukian, Christopher E., Leitner, Wolfgang W., Robbins, Paul F., Rosenberg, Steven A., Restifo, Nicholas P.
Publicado em 2001

Distinctive Features of the Differentiated Phenotype and Infiltration of Tumor-reactive Lymphocytes in Clear Cell Renal Cell Carcinoma

Por Wang, Qiong J., Hanada, Ken-ichi, Robbins, Paul F., Li, Yong F., Yang, James C.
Publicado em 2012

Bcl-2 Overexpression Enhances Tumor-Specific T-Cell Survival

Por Charo, Jehad, Finkelstein, Steven E., Grewal, Navrose, Restifo, Nicholas P., Robbins, Paul F., Rosenberg, Steven A.
Publicado em 2005

Immunization of Patients with the hTERT:540-548 Peptide Induces Peptide-Reactive T Lymphocytes That Do Not Recognize Tumors Endogenously Expressing Telomerase

Por Parkhurst, Maria R., Riley, John P., Igarashi, Takehito, Li, Yong, Robbins, Paul F., Rosenberg, Steven A.
Publicado em 2004

Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma

Por Robbins, Paul F., El-Gamil, Mona, Li, Yong F., Zeng, Gang, Dudley, Mark, Rosenberg, Steven A.
Publicado em 2002

T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product

Por Huang, Jianping, El-Gamil, Mona, Dudley, Mark E., Li, Yong F., Rosenberg, Steven A., Robbins, Paul F.
Publicado em 2004

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms

Por Trebska-Mcgowan, Kasia, Bharathan, Mini, Gartner, Jared J, Prickett, Todd D, Rosenberg, Steven A, Robbins, Paul F
Publicado no J Immunother Cancer (2015)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression

Por Stevanović, Sanja, Anna, Pasetto, Gartner, Jared J, Tran, Eric, Robbins, Paul F, Rosenberg, Steven A, Hinrichs, Christian S
Publicado no J Immunother Cancer (2015)

Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide Bond

Por Cohen, Cyrille J., Li, Yong F., El-Gamil, Mona, Robbins, Paul F., Rosenberg, Steven A., Morgan, Richard A.
Publicado em 2007

Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells

Por Parkhurst, Maria R., Joo, Jayne, Riley, John P., Yu, Zhiya, Li, Yong, Robbins, Paul F., Rosenberg, Steven A.
Publicado em 2009